Related Experiment Video
Updated: Jan 12, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Deep neural networks reveal organic pollutants' dominance in global inflammatory bowel disease
Iman Waheed Khan1, Muhammad Mueed Khan2, Anthony Donato1
1Department of Internal Medicine, Tower Health Hospital, 420 S. Fifth Avenue, Reading 19611, PA, USA.
Abstract:
Inflammatory bowel disease (IBD) is increasing globally, with risk factors still poorly understood and influenced by both genetic and environmental factors. The role of atmospheric pollutants, particularly precursor organic pollutants contributing to < 2.5 µm size particulate matter (PM2.5), remains unclear. In this multi-decadal global study, we investigated their contribution to IBD prevalence using data from the Global Burden of Disease (GBD, 1990-2019), NASA's MERRA-2, and AERONET datasets. A graph neural network (GNN) modeled spatio-temporal dependencies and incorporated immune dysfunction and socio-economic disparities. The dataset was split into 75 % training and 25 % testing, achieving mean squared errors of 4.3 % and 4.6 % respectively, with strong predictive validity (R2 = 0.87). A 10 % global increase in organics was associated with a rise in odds ratio (OR) by 0.21 (95 % CI: 0.12-0.29, p< 0.001), compared to a smaller OR increase of 0.04 (95 % CI: 0.01-0.09, p< 0.001) for PM2.5. Regional disparities were evident, with Sub-Saharan Africa exhibiting higher odds ratios (OR = 1.25; 95 % CI: 1.09-1.43, p< 0.01) than North America (OR = 1.08; 95 % CI: 1.03-1.24, p< 0.05) at an organic burden of 5 µg/m³. However, this trend reversed at higher exposure (25 µg/m³), where the OR for North America approaches 2, while Sub-Saharan Africa plateaued near 1.5. Notably, particles under 100 nm posed the greatest risk. Concluding, organic pollutants play a disproportionate and size-dependent role in IBD prevalence, with significant regional variability. This underscores the need to consider organics as a distinct environmental risk factor in IBD epidemiology.
More Related Videos
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

